Filing Details
- Accession Number:
- 0000899243-21-044599
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-15 16:49:48
- Reporting Period:
- 2021-11-12
- Accepted Time:
- 2021-11-15 16:49:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1537917 | Tyme Technologies Inc. | TYME | Pharmaceutical Preparations (2834) | 453864597 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1710484 | James Biehl | C/O Tyme Technologies, Inc. 1 Pluckemin Way - Suite 103 Bedminster NJ 07921 | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-11-12 | 10,000 | $0.95 | 75,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 150 | Indirect | See footnote |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.9438 to $0.955, inclusive, on November 12, 2021.
- 150 shares are owned by Mr. Biehl's spouse.